Latvia - Respiratory System Medicine Use
Since 2014, Latvia Respiratory System Medicine Use increased 0.1% year on year. In 2019, the country was number 25 among other countries in Respiratory System Medicine Use at 51.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Canada, which was ranked number 24 at 56.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Italy at 45.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway ranked the highest with 230.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 6% versus 2018. Sweden, Finland and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +10.6% per year, while Slovakia was the worst growing country at -8.4% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 51.10 |
| 2018 | 50.30 |
| 2017 | 50.30 |
| 2016 | 47.60 |
| 2015 | 49.60 |
How does Latvia rank in Respiratory System Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
230 | 2019 | +6.0 % | +3.3 % | View data | |
| 2 |
#2
Sweden
|
206 | 2019 | +6.1 % | +3.9 % | View data | |
| 24 |
#24
Canada
|
56 | 2019 | +1.8 % | +10.6 % | View data | |
| 25 |
#25
Latvia
|
51 | 2019 | +1.6 % | +0.1 % | View data | |
| 26 |
#26
Italy
|
45 | 2019 | +3.9 % | -2.5 % | View data | |